< Zurück zu den aktuellen Neuigkeiten & Events

Artikel

Protect It Before You Promote It: IP Advice for MedTech Innovators

Oktober 2025

Developed a new medical product? Check.

Got tickets to an exciting MedTech conference to show off your new product? Check.

Intellectual property? Pardon?

In the excitement of bringing a new MedTech product to market it can be easy to overlook or leave intellectual property issues until later. Don’t!

Intellectual property issues are best sorted out upfront and before any greater potential issues arise.

In developing your product, you may want, or need, to give it to focus groups and users to try and test so they can benefit from your product before it goes to market. You’ll need to be able to discuss your product with them and receive their feedback. They will need to be able to use and experience the product to evaluate it. You want to do this in an open and collaborative environment, but without jeopardising your intellectual property rights. This is much easier if it is understood, by everyone involved, what is confidential. Nobody wants to be looking over their shoulder wondering if a previous collaboration or focus group discussion will negatively impact a patent application.  You may worry that conversations about intellectual property ownership are tricky or potentially off putting to those you wish to work with, but issues that feel large at the outset are likely to evaporate on discussion – so be bold and have open, upfront, discussions about confidentiality and ownership so you know what is yours to protect.

The same goes for collaborators. If you identify who owns which aspects of the intellectual property at the start of the relationship and throughout the development process, it will be much easier to address any ownership matters, than having to rake it over and remember who came up with which element. Who wants to have an acrimonious conversation about the legal stuff afterwards, when you really want to get your new medical product out there and helping those who need it? No one.

Furthermore, improperly laying out relationships can result in poor outcomes when trying to protect the product. Can you prove you owns the intellectual property? Is an assignment in place transferring intellectual property to your company? Without a clear legal chain of ownership in place, any patent or design applications may be vulnerable to attack. It may be difficult to show you own an invention and are entitled to file patents for it. Despite how beneficial your new product is to patients, an unproven or unclear chain of ownership may cause your IP protection to fall down on a technicality.

If you are unsure what should be kept secret, what should be protected, or what you can more freely discuss during your product developments and marketing, HGF can help. We are experts in identifying any intellectual property you have, and devising and implementing protection strategies to help you avoid IP pitfalls.

Don’t let intellectual property issues get in the way of marketing and delivering your new medical product to those who need it. Be bold, have conversations up front and ensure you’ve laid the groundwork to make sure you’re protected. Then go and enjoy that conference.


This article was written by Patent Director Frazer Bye.

Aktuelle Neuigkeiten

Event - 11. bis 12. Mai 2026

HGF ist stolz darauf, am 14th Microbiome R&D and Business Collaboration Forum: Europe sowie am 8th Skin Microbiome and Cosmeceuticals Congress: Europe teilzunehmen.

HGF ist stolz darauf, am 14th Microbiome R&D and Business Collaboration Forum: Europe sowie am 8th Skin Microbiome and Cosmeceuticals Congress: Europe teilzunehmen. Die Veranstaltung findet am Montag, den 11., …

Veranstaltungsdetails
Event - 27. April 2026

HGF are proud to be Gold Sponsors of IP Counsel Café

HGF are proud to be Gold Sponsors of IP Counsel Café on 12-14th May at Silicon Valley, US. HGF Partner Susan Keston will be speaking at on the topic AI …

Veranstaltungsdetails

Seven HGF Attorneys Recognised in the 2026 Pro Bono Recognition List

We’re proud to share that seven of our attorneys have been named on the 2026 Pro Bono Recognition List of England & Wales, recognising those who have dedicated 25 hours …

Weiterlesen

PRESSEMITTEILUNG Oliver Pooley tritt am 21. April 2026 als Partner bei HGF ein.

HGF freut sich, die Ernennung von Oliver Pooley bekannt zu geben, der dem Unternehmen am 21. April 2026 als Partner beitreten wird. Oliver verstärkt die Technology & Engineering Group von …

Weiterlesen
Event - 16. April 2026

MedTech Innovation Summit 2026

Adam Hines, Partner bei HGF und Patentanwalt, wird am MedTech Innovation Summit Dublin 2026 teilnehmen, der vom 28. bis 30. April im The Shelbourne Hotel stattfindet. Als eine der führenden …

Veranstaltungsdetails
Event - 2. bis 6. Mai 2026

INTA-Jahrestagung 2026

Das europäische Team von HGF freut sich, an der INTA-Jahrestagung 2026 teilzunehmen, die vom 2. bis 6. Mai in London stattfindet. Als eine der führenden IP-Kanzleien Europas vereint HGF Anwältinnen …

Veranstaltungsdetails
Event - 25. März 2026

HGF‑Event: Women IP Inclusive

Dieses Jahr organisiert HGF in Partnerschaft mit dem CIPA das Networking‑Event Connected Bubbles – am Mittwoch, den 25. März 2026! In einem Berufsfeld, das auf Zusammenarbeit, Empfehlungen und Vertrauen basiert, …

Veranstaltungsdetails
Event - 16., 17. März 2026

HGF ist Sponsor der IQPC Europe 2026

HGF ist stolz darauf, den Global IP Exchange Europe 2026 von IQPC zu sponsern, ein exklusives Forum nur auf Einladung, das führende interne IP-Entscheidungsträger aus ganz Europa zusammenbringt. In einer …

Veranstaltungsdetails